Novo Nordisk receives FDA approval for Wegovy™ to treat adults with obesity based on unprecedented efficacy for a prescription medicine in clinical trials ...Middle East

PLAINSBORO, N.J., June 4, 2021 /PRNewswire/ -- Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved the new drug application (NDA) for Wegovy™ (semaglutide) injection 2.4 mg, the first-and-only prescription weight-loss medication with once-weekly dosing....

Hence then, the article about novo nordisk receives fda approval for wegovy to treat adults with obesity based on unprecedented efficacy for a prescription medicine in clinical trials was published today ( Friday 04/06/2021 - 11:02 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Novo Nordisk receives FDA approval for Wegovy™ to treat adults with obesity based on unprecedented efficacy for a prescription medicine in clinical trials )

Also on site :

• Emmys 2026: ‘Widow’s Bay’ Leads All New Shows With 19 Nominations
• Dem Sen. Mark Kelly's Warning About How Trump Might Try to 'Intimidate Voters' Is Backfiring Hard
• Northwest Biotherapeutics Presents Updated Survival Data from Phase III Trial of DCVax®-L For Glioblastoma Using Individual Patient Level Data in Multiple Independent Analyses